Teva Pharmaceutical Industries Limited (OTCMKTS: TEVA) today announced the Ministry of Health, Labor, and Welfare (MHLW) had approved AJOVY injection for the preventive treatment of migraine in grownups in Japan. AJOVY® designed for the deterrent cure of migraine “In Japan is 8.4% of adults are yearly suffereing from migraine. Along […]